<DOC>
	<DOCNO>NCT01226290</DOCNO>
	<brief_summary>The primary objective study establish effectiveness confirm safety VizAblate System ablate symptomatic uterine fibroid .</brief_summary>
	<brief_title>Fibroid Ablation Study</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<criteria>28 year age old Regular , consistent menstrual cycle History excessive bleed One Menstrual Pictogram score ≥ 120 onemonth screen period Baseline Uterine Fibroid Symptom &amp; Quality Life ( UFSQOL ) Symptom Severity Subscale ( SSS ) score ≥ 20 Between 1 5 Target Fibroids 1 cm 5 cm and/or maximum volume 82.4cc At least one fibroid must indent endometrium Subject material risk pregnancy . Subject willing maintain use nonuse hormonal contraception Subject willing uniform maintenance ( use nonuse ) antifibrinolytic nonsteroidal antiinflammatory agent Subserosal fibroid bulk symptom Presence type 0 intracavitary fibroid Any Target Fibroid &gt; 5 cm maximum diameter volume &gt; 82.4cc Any fibroid obstructs access VizAblate probe Postmenopausal history Desire current future fertility Hemoglobin &lt; 6 g/dl Pregnancy Evidence disorder hemostasis Use Gonadotropinreleasing hormone ( GnRH ) agonist implantable injectable progestin and/or estrogen , Selective Estrogen Receptor Modulators ( SERM ) selective progesterone receptor modulator ( SPRM ) Shortterm use hormonal medication management bleed Evidence current cervical dysplasia Endometrial hyperplasia Confirmed abdominal / pelvic malignancy within previous five year Active pelvic infection Clinically significant adenomyosis Previous uterine artery embolization . Previous surgical ablative treatment fibroid menorrhagia within previous 12 month Current use anticoagulant therapy Need emergency surgery treat fibroid symptom Concomitant intrauterine polyp &gt; 1.0 cm Contraindication MRI Renal insufficiency Uncontrolled hypertension last 2 year One treatable fibroid calcify Chronic pelvic pain Presence extrauterine pelvic mass Presence tubal implant sterilization Previous pelvic irradiation Endometrial cavity length &lt; 4.5 cm</criteria>
	<gender>Female</gender>
	<minimum_age>28 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>uterine fibroid RF ablation</keyword>
	<keyword>intrauterine ultrasound</keyword>
	<keyword>VizAblate</keyword>
</DOC>